As you were in attendance at the AGM I was wondering if there was any indication as to where the Commercial Partner geographically may come from ? As one of the posts on this thread highlighted that both India & China are potentially enormous markets and given we will need to proceed in future with FDA approval I am throwing up the value of Dr Reddy's being a possible partner. I am still of the opinion that given the focus on Europe that the initial preference is for a European partner. Welcome your thoughts. As I see this decision the biggest in our share spike before year end.
TIS Price at posting:
42.9¢ Sentiment: Buy Disclosure: Held
